KHK-IN-5
Product Specifications
UNSPSC Description
KHK-IN-5 (Compound 18) is a KHK inhibitor. KHK-IN-5 can be used for the research of nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and type 2 diabetes (T2DM)[1].
Target Antigen
Ketohexokinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/khk-in-5.html
Smiles
N#CC(C(C(F)F)=CC(N1C[C@@]2([H])[C@@](CNC2)([H])C1)=N3)=C3NC4=C(C=CC=C4)SC
Molecular Weight
401.48
References & Citations
[1]Sabnis RW. Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II Diabetes. ACS Med Chem Lett. 2024 Jul 23;15(8):1191-1192.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163886/KHK-IN-5-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163886/
Clinical Information
No Development Reported
CAS Number
3043939-40-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1067881-01 50 mg
4,4',4'',4''',4'''',4'''''- ((1,3,5,2L5,4,6-triazatriphosphinine-1,2,2,4,5,6-hexayl) hexakis (oxy) ) hexaaniline
Ask
View Details 
OR1067881-02 100 mg
4,4',4'',4''',4'''',4'''''- ((1,3,5,2L5,4,6-triazatriphosphinine-1,2,2,4,5,6-hexayl) hexakis (oxy) ) hexaaniline
Ask
View Details OR1067881-03 250 mg
4,4',4'',4''',4'''',4'''''- ((1,3,5,2L5,4,6-triazatriphosphinine-1,2,2,4,5,6-hexayl) hexakis (oxy) ) hexaaniline
Ask
View Details 
OR1067881-04 1 g
4,4',4'',4''',4'''',4'''''- ((1,3,5,2L5,4,6-triazatriphosphinine-1,2,2,4,5,6-hexayl) hexakis (oxy) ) hexaaniline
Ask
View Details